Structural Mechanism of N-Methyl-D-Aspartate Receptor Type 1 Partial Agonism
Ylilauri, M., & Pentikäinen, O. (2012). Structural Mechanism of N-Methyl-D-Aspartate Receptor Type 1 Partial Agonism. PLoS One, 7 (10), e47604. doi:10.1371/journal.pone.0047604 Retrieved from http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047604
Published inPLoS One
DisciplineSolu- ja molekyylibiologia
© 2012 Ylilauri, Pentikäinen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
N-methyl-D-aspartate (NMDA) receptors belong to a family of ionotropic glutamate receptors that contribute to the signal transmission in the central nervous system. NMDA receptors are heterotetramers that usually consist of two GluN1 and GluN2 monomers. The extracellular ligand-binding domain (LBD) of a monomer is comprised of discontinuous segments that form the functional domains D1 and D2. While the binding of a full agonist glycine to LBD of GluN1 is linked to cleft closure and subsequent ion-channel opening, partial agonists are known to activate the receptor only sub-maximally. Although the crystal structures of the LBD of related GluA2 receptor explain the mechanism for the partial agonism, structures of GluN1-LBD cannot distinguish the difference between full and partial agonists. It is, however, probable that the partial agonists of GluN1 alter the structure of the LBD in order to result in a different pharmacological response than seen with full agonists. In this study, we used molecular dynamics simulations to reveal an intermediate closure-stage for GluN1, which is unseen in crystal structures. According to our calculations, this intermediate closure is not a transient stage but an energetically stable conformation. Our results demonstrate that the partial agonist cannot exert firm GluN1-LBD closure, especially if there is even a small force that disrupts the LBD closure. Accordingly, this result suggests the importance of forces from the ion channel for the relationship between pharmacological response and the structure of the LBD of members of this receptor family. ...
MetadataShow full item record
Except where otherwise noted, this item's license is described as © 2012 Ylilauri, Pentikäinen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Showing items with similar title or keywords.
Postila, Pekka; Swanson, Geoffrey; Pentikäinen, Olli (2010)Ionotropic glutamate receptors (iGluRs) are enticing targets for pharmaceutical research; however, the search for selective ligands is a laborious experimental process. Here we introduce a purely computational procedure ...
Postila, Pekka (University of Jyväskylä, 2010)
Elucidating the ligand shell structure and dynamics of Au683MBA32 gold nanocluster using molecular dynamics simulations Lautala, Saara (2017)Synthesising novel gold nanoparticles and -clusters can be often easier than characterising them, and after experimental analysis many options for the possible molecular formula of the cluster may remain as equally valid ...
The Role of Small-Angle X-Ray Scattering and Molecular Simulations in 3D Structure Elucidation of a DNA Aptamer Against Lung Cancer Morozov, Dmitry; Mironov, Vladimir; Moryachkov, Roman V.; Shchugoreva, Irina A.; Artyushenko, Polina V.; Zamay, Galina S.; Kolovskaya, Olga S.; Zamay, Tatiana N.; Krat, Alexey V.; Molodenskiy, Dmitry S.; Zabluda, Vladimir N.; Veprintsev, Dmitry V.; Sokolov, Alexey E.; Zukov, Ruslan A.; Berezovski, Maxim V.; Tomilin, Felix N.; Fedorov, Dmitri G.; Alexeev, Yuri; Kichkailo, Anna S. (Elsevier, 2021)Aptamers are short, single-stranded DNA or RNA oligonucleotide molecules that function as synthetic analogs of antibodies and bind to a target molecule with high specificity. Aptamer affinity entirely depends on its tertiary ...
Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine Wyhe, Laura Leanne Lash-van; Postila, Pekka; Tsubone, Koichi; Sasaki, Makoto; Pentikäinen, Olli; Sakai, Ryuichi; Swanson, Geoffrey (2010)Kainate receptor antagonists have potential as therapeutic agents in a number of neuropathologies. Synthetic modification of the convulsant marine toxin neodysiherbaine A (NDH) previously yielded molecules with a diverse ...